Adrian Smith

Adrian Smith currently serves as Chief Executive Officer at OGT, focusing on advancing genetic-based medicine to improve patient care decisions since March 2022. In addition, Adrian holds a position as Non Executive Board Member at Diagnostics for the Real World, working on innovative point of care diagnostics for infectious diseases since October 2022. Previous roles include General Manager/Managing Director at Hologic, Inc. from September 2014 to March 2022, and Associative Marketing Director at QIAGEN from March 2011 to September 2014. Adrian's earlier experience includes roles at Roche in government affairs, market access, sales, and marketing, as well as Regional Sales Manager at PENTAX Medical. Adrian's educational background includes a BSc (hons) in Biochemistry and Applied Molecular Biology from The University of Manchester and an Executive Programme in Marketing Strategy and Implementation from London Business School.